Comparison Between the I-gel and Protector Supraglottic Airway Devices
NCT ID: NCT06938308
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2025-04-22
2025-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
LMA I-Gel Versus LMA Protector During Minor Urological Procedures Under General Anesthesia in Adult Patients
NCT06825910
Comparison Study of Two Supraglottic Airway Devices Used for Patients Under General Anesthesia
NCT01001078
Comparison of Two Type of Laryngeal Mask : I-Gel & LMA ProSeal
NCT00624403
Laryngeal Mask Supreme™ Versus the I-gel™
NCT00653237
Comparison of the LMA Protector and the I-gel
NCT03078517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LMA Igel group
LMA Igel
adults allocated to the LMA Igel group, an LMA Igel device will be inserted intraoperatively
LMA Protector group
LMA Protector
adults allocated to the LMA Protector group, an LMA Protector device will be inserted intraoperatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LMA Igel
adults allocated to the LMA Igel group, an LMA Igel device will be inserted intraoperatively
LMA Protector
adults allocated to the LMA Protector group, an LMA Protector device will be inserted intraoperatively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients older than 18 years
* Procedures in supine and lithotomy position
Exclusion Criteria
* Known history of difficult intubation
* Limited mouth opening less than 2cm
* Decreased compliance of the lungs or the thoracic cage
* Need of mechanical ventilation after the surgery
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nikolopoulou Maria Zozefin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nikolopoulou Maria Zozefin
Anesthesiology Resident at Sismanoglio General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SismanoglioGH
Athens, Attica, Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9254/10-04-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.